Furthermore, NNK can activate BCL-2 to inhibit apoptosis of SCLC cells, whereas PKC inhibitor staurosporine, ERK1-ERK2 inhibitor PD98059, or knockdown of MYC can block the effect [63]. The gene discussed is MAPK1; the disease is small cell lung carcinoma.